A cDNA encoding a novel member of the helicase family, MDDX28, has been cloned from a human testis library. This apparently intronless gene was transcribed in all tissues studied. MDDX28 encodes a protein of 540 amino acids, with ϳ30% homology to other helicases over the core region, containing all the conserved DEAD-box helicase motifs. No homologue is known. MDDX28 has RNA and Mg 2؉ -dependent ATPase activity. Subcellular localization studies of MDDX28 using oligoclonal antibodies raised against the protein as well as its enhanced green fluorescence protein (EGFP) demonstrated that the protein is localized in the mitochondria and the nucleus. To our knowledge, MDDX28 is the first member of the RNA helicase described with this dual location. The nuclear localization of MDDX28 depended on active RNA polymerase II transcription, suggesting that the protein could be transported to and from the nucleus. This was confirmed further in an interspecies heterokaryon assay, in which MDDX28 was seen to translocate to the nucleus and mitochondria. The mitochondrial uptake of the MDDX28-EGFP-N1 fusion protein was inhibited by carbonyl cyanide p-(trichloromethoxy)phenylhydrazone. Our results indicate that MDDX28 can be transported between the mitochondria and the nucleus.
RNA helicases constitute a family of proteins that unwind double-stranded RNA by using nucleoside triphosphates as a source of energy. They are characterized by a conserved core region of ϳ300 amino acids that contains eight highly conserved domains. Some of these motifs are involved in hydrolyzing NTP, mainly ATP, and in coupling the hydrolysis to the unwinding process. RNA helicases have also been nicknamed DEAD-box helicases after the conserved motif II, the so-called DEAD box (Asp-Glu-Ala-Asp). Amino acid variation in the DEAD-box motif further divides the RNA helicases into three subfamilies, subsequently called the DEAD, DEAH, and DExH families (reviewed in Ref. 1) .
The number of members assigned to the DEAD-box family has increased substantially over the past few years. They have been found in all organisms and many viruses. RNA helicases form a diverse group of enzymes participating in essentially all cellular processes that involve RNA: transcription, translation, splicing, ribosome biogenesis, RNA transport, etc.
Helicase activity has only been demonstrated for a few of the proteins grouped as members of the RNA helicase family. However, many of these proteins hydrolyze NTP, mainly ATP, in the presence of RNA and are therefore RNA-dependent NTPases or putative helicases. This may in part reflect their substrate specificity or cofactor requirements for RNA helicase activity.
Mitochondria have their own DNA (mtDNA) with local replication, transcription, and translation functions. The majority of their proteins are encoded by nuclear genes and transported into the mitochondria. A few of these proteins are shared between the mitochondria and the rest of the cell. In some cases separate isoforms of the same protein are transported either to the nucleus or to the mitochondria (2) . In other cases, different genes in the nuclear genome code for proteins that perform the same function in mitochondria and elsewhere in the cell. Examples of this are the proteins of the mitochondrial ribosomes that share little homology with those of cytoplasmic ribosomes (3) .
Four putative RNA helicases located to mitochondria have been described in other organisms. Two are found in yeast: Suv3, which belongs to the DExH subfamily (4) , and Mss16 (5) . Both are involved in splicing. An orthologue of the Suv3 helicase, AtSuv3, has been cloned from Arabidopsis thaliana (6) . A putative mitochondrial RNA helicase, mHel16, involved in mitochondrial mRNA editing has been cloned in Trypanosoma brucei (7) .
We have cloned a human gene that encodes a novel member of the DEAD-box family, MDDX28 1 (mitochondrial DEAD-box polypeptide 28). This protein contains the highly conserved DEAD-box helicase motifs and has ϳ30% similarity to other DEAD-box helicases, but no real homologue has been described. The protein is localized to both the mitochondria and the nucleus and is to our knowledge the first member of the RNA helicase family described with this dual localization.
EXPERIMENTAL PROCEDURES
Cloning of the MDDX28 Gene and Construction of Plasmids-The MDDX28 gene was cloned by CpG island subcloning from the human chromosome 16q22.1 as part of an ongoing mapping and sequencing project in our laboratory (8 -11) . Probes from a previously characterized gene cluster (8) were used to screen high density filters containing the human P1-derived artificial chromosome library RPCI-1 (Refs. 12 and * This work was supported by grants from the Research Council of Norway, the Norwegian Cancer Society, and the Jahre Foundation (to H. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The 13; described at www.chori.org/bacpac). Fragments containing a previously localized CpG island were subcloned into pZero-2 to give, among others, pEco29 (2.9 kb, 2 GenBank TM Accession Number AF329821) and pKURT (a 1.1-kb insert in pEco29, from base 179 -1346) (10, 11) . Three clones were obtained from a human testis cDNA library (kindly provided by Dr. K. Taskèn, University of Oslo) and hybridized to pEco29. Deletion clones were made from pEco29, pKURT, and the cDNA clones and sequenced on an ALF DNA Sequencer (Amersham Pharmacia Biotech). The sequences were aligned using the Gene Skipper program (14) .
To make the MBP-MDDX28 fusion protein for purification, the MDDX28 gene was polymerase chain reaction-amplified from the genomic clone (pEco29u) using the PfuII enzyme (Stratagene). Both the forward (GGGATCCATGGCTCTAGCGCGGCCGG) and the reverse (GGGGATCCCTCAGGTTGCTTGGGGCAA) primers introduced BamHI sites. The insert was subcloned using EcoRV sites into pZero-2 (Invitrogen) and with BamHI sites into pMal-cRI (New England Biolabs) in XL1-Blue cells (Stratagene). The construct was moved into the protease-deficient strain 801-K (New England Biolabs).
The MDDX28 gene was also cloned into the pEGFP-N1 vector (CLONTECH) with polymerase chain reaction using PfuII and the forward primer GGGATCCAGCCACCATGGCTCTAGCGCGGCCGG and the reverse primer GGTGGATCCAAGGTTGCTTGGGGCAAAGGC via EcoRV-digested pZero.
Expression and Purification of MDDX28 -The MBP-MDDX28 fusion protein was expressed in Escherichia coli 801-K according to instructions from New England Biolabs. The bacterial pellet was resuspended in binding buffer (10 mM Tris-Cl, pH 7.5, 200 mM NaCl, 1 mM EDTA, and 10 mM ␤-mercaptoethanol) and lysed by sonication. The insoluble material was removed by centrifugation. The supernatant was filtered through a 0.22-m Cameo 25 gas filter (Micron Separations, Inc.) and loaded onto an amylose resin column (New England Biolabs). The column was washed with 15 volumes of the binding buffer, and the protein was eluted with binding buffer containing 10 mM D-(ϩ) maltose (Janssen Chimica). The purified protein was concentrated on a 10K Microsep centrifugal concentrator (Pall Filtron) and further purified on a HiLoad 16/60 Prepgrade Superdex column (Amersham Pharmacia Biotech).
Cleaving of the fusion protein was attempted with factor Xa (Hematologic Technologies) at an ϳ1:50 (enzyme/substrate) molar ratio, but this resulted in degradation of the MDDX28 protein, which has several putative cleavage sites for factor Xa. The MBP part of the fusion protein, however, remained intact and was used as a negative control in the ATPase assay.
Northern Analysis-The insert from pKURT was hybridized to a human multiple-tissue Northern blot membrane (CLONTECH) using standard methods.
The mRNA half-life was estimated in COS-1 cells treated with 10 g/ml actinomycin D (Sigma). The cells were harvested by washing in ice-cold PBS, then scraped off into 0.6 ml of lysis buffer (100 mM Tris-HCl, pH 8.0, 500 mM LiCl, 10 mM EDTA, 1% lithium dodecyl sulfate, and 5 mM dithiothreitol), and sheared with a 21-gauge syringe. For the isolation of mRNA, oligo(dT)-conjugated magnetic beads (Dynal) were used according to manufacturer instructions. Samples were run on agarose/formaldehyde gels in MOPS buffer and blotted in 10ϫ SSC buffer. Prehybridization and hybridization were performed in ExpressHyb TM solution (CLONTECH). For the detection of MDDX28, a 1.1-kb insert from pEco29 was used (p1b2a, from base pairs 1608 -2751). Complete cDNA was used to generate a probe for glyceraldehyde-3-phosphate dehydrogenase. The filters were scanned on STORM 860 (Molecular Dynamics), and quantification was done with ImageQuant 5.1 (Molecular Dynamics).
Raising of Antibodies-Rabbit oligoclonal antibodies were raised against two peptides from MDDX28 (QRQLEQRQSRRRNLPR, position 43-58 (Ab27), and KSRRARRDHFSIERAQQE, position 98 -115 (Ab29)) selected for their hydrophilicity. The peptides were synthesized using an ABI 430A, purified by high pressure liquid chromatography, coupled to keyhole limpet hemocyanine, and injected into rabbits. The antibodies were purified on a protein G column (Amersham Pharmacia Biotech), concentrated on a 10K Microsep centrifugal concentrator (Pall Filtron) to 10 mg/ml, aliquoted, and kept at Ϫ20°C until use.
Cell Culture and Immunofluorescence-COS-1 cells were grown on coverslips in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 10% fetal calf serum (Integro) and 2 mM L-glutamine (Life Technologies, Inc.). At the appropriate times, the coverslips were washed briefly in PBS and fixed in 4% paraformaldehyde (PFA) for 15 min. The cells were permeabilized in 0.5% Triton X-100 in PBS, washed with 0.1% Triton X-100 in PBS, and blocked for 30 min in 3% bovine serum albumin in PBS with 0.1% Triton X-100. The samples were incubated with the primary antibody at 4°C overnight, washed three times, and incubated for 1 h with fluorescein isothiocyanate-labeled secondary antibody (DAKO). When appropriate, the cells were counterstained with 4Ј,6-diamidino-2-phenylindole (Sigma) or Cy-3-conjugated ExtrAvidin (Sigma) before mounting. The samples were viewed with a Nikon Eclipse E400 microscope, and the pictures were taken with a SPOT digital camera and combined with SPOT32 software (Diagnostic Instruments).
The MDDX28-EGFP-N1 construct was transfected into COS-1 cells using the FuGene6 transfection reagent in a 4:1 FuGene/plasmid ratio according to the Roche protocol.
Subcellular Fractionation-COS-1 cells were treated as described by Burtelow et al. (15) with minor changes to yield mitochondrial and nuclear fractions. Briefly, the cells were washed in PBS and lysis buffer (25 mM Hepes, pH 7.5, 5 mM MgCl 2 , 5 mM EDTA, 10 g/ml aprotinin, 10 g/ml leupeptin, 10 g/ml antipain, 10 g/ml chymostatin, 10 g/ml phosphoramidon, and 1 mM phenylmethylsulfonyl fluoride) and incubated on ice for 20 min. The cells were then homogenized, and the buffer was adjusted to 250 mM sucrose (Sigma) with lysis buffer containing 1 M sucrose. Cells were centrifuged at 800 ϫ g for 10 min to obtain the nuclear fraction. The supernatant was then centrifuged at 4000 ϫ g for 15 min to obtain a mitochondria-containing pellet. The protein components of the fractions were used in immunoblotting experiments with the MDDX28-specific antibody (Ab27). The fractionation was checked by immunoblotting with antibody against the nucleolar protein NO38 (a kind gift from Dr. Trond Stokke, The Norwegian Radiumhospital, Oslo, Norway).
Translation and Transcription Inhibition-Transiently transfected COS-1 cells were grown for 20 -24 h on coverslips before treatment with the following transcription or translation inhibitors: 10 g/ml actinomycin D (Sigma), 10 g/ml ␣-amanitin (Sigma), 100 g/ml 5,6-dichloro-1-␤-D-ribofuranosylbenzimidazole (DRB) (Calbiochem), 10 M Tagetin (Epicentre), or 10 g/ml cycloheximide. At various times the cells were fixed as described above and viewed immediately in the fluorescence microscope. The samples were scored blindly for nuclear localization of the fusion protein by counting at least 100 cells/sample.
ATP Hydrolysis Assay-ATPase activity of purified MBP-MDDX28 protein was measured as described by Iggo and Lane (16) . Briefly, to 30 l of ATPase buffer (150 mM NaCl, 5 mM KCl, 1.5 mM MgCl 2 , and 1 mM dithiothreitol in 20 mM Hepes, pH 7.0) containing 5 l of purified fusion protein (2.5 g, estimated from a silver-stained gel) or controls, 200 pmol of cold ATP and 1 pmol of [␥-32 P]ATP (Amersham Pharmacia Biotech) were added. The samples were incubated at 37°C. At each time point, 5 l of sample were withdrawn and added to 300 l of 7% activated charcoal (Sigma) in 50 mM HCl/5 mM H 3 PO 4 . The charcoal was precipitated by centrifugation (10 min at 11,000 ϫ g) to remove unreacted ATP. The supernatant (100 l) was mixed with Pico Aqua liquid scintillation mixture (Packard) and counted in a Packard 1600TR liquid scintillation analyzer.
Mitochondrial Import-COS-1 cells were grown on coverslips and transfected with MDDX28-EGFP-N1. Five h post-transfection 100 M carbonyl cyanide p-(trichloromethoxy)phenylhydrazone (CCCP, Sigma) was added to the cell culture, and the cells were incubated for an additional 5 h. The cells were then fixed in 4% PFA and viewed with a Nikon Eclipse E400 microscope.
Heterokaryon Assay-Heterokaryon assays were performed as described by Cà ceres et al. (17) . Briefly, COS-1 cells were grown on coverslips and transfected with MDDX28-EGFP-N1. Twenty to twentyfour h post-transfection, excess untransfected NIH/3T3 cells were added to the COS-1 culture and incubated in the presence of 50 g/ml cycloheximide for 3 h. The cycloheximide concentration was then increased to 100 g/ml for 0.5 h before the cells were washed in PBS and fused for 2 min with PEG-4000 (Merck). The cells were then washed thoroughly in PBS and incubated in fresh medium containing 100 g/ml of cycloheximide. One h later the cells were fixed in 4% PFA and counterstained with Hoechst 33258 (Sigma) to distinguish COS-1 and NIH/3T3 cells. The samples were viewed with a Nikon Eclipse E400 microscope. When appropriate, 100 M CCCP was added to the cell culture immediately after the fusion, and the cells were fixed 1 h later.
RESULTS
The MDDX28 Gene-The 5Ј end of the MDDX28 gene lies within a sequence that shows CpG island characteristics (Ref. 18 ; Fig. 1) . A 5Ј-rapid amplification of cDNA ends was attempted, but it did not give interpretable results, probably because of the high GC content (data not shown). Therefore, the start site of the gene has not been determined conclusively. However, we assumed a start site at the only ATG within the CpG island, which was followed by an open reading frame, consistent with the size of the MDDX28 mRNA and protein.
The gene spans 1623 base pairs from the proposed start site and ends with TGA. A canonical polyadenylation signal AAUAAA is found 253 base pairs downstream of the stop codon, and the cDNA clone continues for an additional 20 base pairs before the poly(A) tail starts. This indicates that the total size of the mRNA is about 2 kb, which agrees with the size seen on Northern blots (Fig. 2) . The cDNA sequence is identical with the genomic sequence with no introns. The corresponding open reading frame indicates a protein of 540 amino acids (Fig. 1) and a calculated molecular mass of 59 kDa containing three cysteine residues. The codon usage pattern does not deviate significantly from the average of mammalian genes. The calculated pI of the MDDX28 protein is ϳ11.
The N-terminal end of MDDX28 has a putative mitochondrial targeting signal (MTS) at amino acids 3-18. This sequence has the MTS characteristics (reviewed in Ref. 19) consisting of 16 amino acids, potentially forming an amphiphilic ␣-helix with a net positive charge (data not shown). MDDX28 has also a putative nuclear localization signal at amino acids 520 -523 (RRRR) and a putative leucine-rich nuclear export signal at amino acids 180 -191 (LSYLLPLLQRLL). There are 19 potential serine sites and four potential threonine sites but no tyrosine phosphorylation sites, as predicted with the NetPhos 2.0 software (20) .
The protein has all the well conserved DEAD-box helicase motifs (Fig. 1) . Sequence similarity searches with BLASTP 2.0.12 (21) revealed ϳ30% similarity with other described putative RNA helicases in a region of 300 -400 amino acids. The similarities are clustered around the conserved motifs. No homologues were found, and MDDX28 did not show any more similarity to previously described mitochondrial RNA helicases than to other RNA helicases (Fig. 3) . A low stringency BLASTP search (21) using the first 130 amino acids of the protein revealed no similarity with previously characterized RNA helicases.
Northern Analysis-Hybridization of pKURT to RNA from various human tissues showed that the MDDX28 transcript is about 2.0 kb. The gene was transcribed in all tissues studied (Fig. 2A) . The half-life of the mRNA was estimated to be 45 min (Fig. 2B) .
RNA-dependent ATPase Activity-The purified recombinant MBP-MDDX28 fusion protein (102 kDa, Fig. 4A ) was used to assess the ATPase activity. As a negative control we used purified MBP, off of which MDDX28 had been cleaved with factor Xa.
The purified fusion protein showed marked ATP hydrolysis activity, whereas MBP alone showed none (Fig. 4B) . MgCl 2 was necessary for the ATPase activity (data not shown). Furthermore, no hydrolysis was observed when ATP was replaced with GTP (data not shown).
The purified recombinant protein was already bound to RNA as observed with UV spectroscopy. This revealed a peak at 260 nm in addition to the peaks at 210 and 280 nm (data not shown). The presence of RNA was confirmed when bacteria grown in the presence of [
14 C]-UTP (Amersham Pharmacia Biotech) were lysed, and the MBP-MDDX28 protein was pulled down using amylose resin. This showed the presence of radioactive RNA that was not present when only MBP was pulled down. To remove the RNA, recombinant protein was treated with 10 g/ml of either RNase T1 or A (Sigma) while the protein was bound to the amylose resin. The beads were subsequently washed to remove the RNase before the protein was eluted from the beads. This resulted in a loss of the ATP hydrolysis activity of the recombinant protein (Fig. 4B) . The ATPase activity was not rescued by the addition of total RNA from COS-1 cells (Fig. 4B) . These results show that the purified MDDX28 protein has ATPase activity that depends on the presence of both RNA and Mg 2ϩ ions. Intracellular Localization of MDDX28 -The MDDX28 protein was C-terminally tagged with enhanced green fluorescence protein (MDDX28-EGFP-N1), and its subcellular localization was studied in transiently transfected cells. The fusion protein was localized in the mitochondria of all the transfected cells (Fig. 5A ). The mitochondrial localization was confirmed by using either an antibody to cyclooxygenase I or Cy-3-conjugated ExtrAvidine (Sigma), which specifically stains mitochondria (Ref. 22 and data not shown). The mitochondrial localization of the MDDX28 protein was predominantly disperse, but apparently the protein was concentrated in one spot in the mitochondria in some cells (Fig. 5B) . The MDDX28 protein was present in the nucleus in about half of the transfected cells. The nuclear signal was disperse, with the protein also present in the nucleoli in a small fraction of the cells (Fig. 5C ). Endogenous MDDX28 stained with the oligoclonal primary antibodies revealed similar mitochondrial-and faint nuclear-staining patterns (Fig. 5E) .
The nuclear localization of the MDDX28-EGFP-N1 fusion protein varied with time post-transfection. Eight h post-transfection, the protein was only present in the mitochondria. The nuclear localization of MDDX28 increased with time posttransfection, reaching a plateau after 24 h when the protein was seen in about half of the cells. The nucleolar signal was seen in up to 20% of the cells 24 h post-transfection but was not detected 48 h post-transfection (data not shown). MDDX28 contains a putative leucine-rich nuclear export signal (Fig. 1) found in proteins exported via the CRM1/exportin 1 pathway, which is sensitive to leptomycin B (23) (24) (25) (26) . The number of transfected cells showing nuclear localization of MDDX28 was not significantly altered when the cells were treated with leptomycin B (100 ng/ml, a kind gift from Dr. B. Wolff-Winiski, Novartis).
No difference was seen in the size of the MDDX28 protein isolated from the nuclear and mitochondrial fractions (Fig. 5F ). The fractionation was controlled with an antibody against the nucleolar protein NO38.
The import of the MDDX28-EGFP-N1 fusion protein to the mitochondria was inhibited when CCCP, an uncoupler of the mitochondrial electron transport that also inhibits the import of proteins to the mitochondria, was added to cell cultures 5 h post-transfection and the cells were cultured for another 5 h (Fig. 6E) . The protein was, however, present in the nucleus of the transfected cells, and excess protein did not appear to accumulate in the cytoplasm.
Inhibition of RNA Transcription-The addition of cycloheximide (10 g/ml) (Fig. 7A) or actinomycin D (10 g/ml, data not shown) to COS-1 cells demonstrated that the level of MDDX28 protein in immunoblotting of cell extracts was essentially constant for at least 24 h. This long half-life made it possible to study the intracellular localization of MDDX28 in response to inhibitors of RNA synthesis even though the mRNA half-life of MDDX28 was short. Twenty-to twenty-four h after the transfection of COS-1 cells with MDDX28-EGFP-N1, the cells were treated with the RNA polymerase inhibitors actinomycin D and ␣-amanitin. This resulted in the disappearance of the fluorescent signal from the nucleus of the majority of cells after a further 24-h incubation (Fig. 7B ), but the mitochondrial signal was retained. This effect became even more apparent when the inhibitors were added earlier (4 -8 h post-transfection, Fig.  7B ). In comparison, cells transfected with EGFP-N1 only (Fig.  5D) showed no change in subcellular localization of the fluo- 
FIG. 5. Subcellular localization of MDDX28.
COS-1 cells were grown on coverslips, transfected with MDDX28-EGFP-N1 (green), fixed 24 h later, and counterstained with 4Ј,6-diamidino-2-phenylindole (A, blue). MDDX28 was localized in the mitochondria in all cells. A, in about half of the cells the fusion protein was detected only in mitochondria. B, the mitochondrial signal was often detected as a strong spot (arrow) in the mitochondria. About half of the cells showed both mitochondrial and nuclear localization with (C) or without (B) nucleolar staining. D, cells transfected with an empty EGFP-N1 vector did not show the specific mitochondrial and nuclear localization. E, detection with MDDX28-specific antibody demonstrated that the endogenous MDDX28 was mostly diffusely located in the nucleus and mitochondria. F, the sizes of the MDDX28 protein in the nuclear (N) and mitochondrial (M) fractions of COS-1 cells were compared in immunoblots. An antibody against the nucleolar protein NO38 was used to control the fractionation. rescent protein upon inhibition with actinomycin D. Inhibition of protein synthesis with 10 g/ml cycloheximide for 24 h had no effect on localization (Fig. 7B) , suggesting that processes related to transcription and not de novo protein synthesis are crucial for the subcellular localization of the MDDX28 protein. Actinomycin D inhibits all RNA transcription, and ␣-amanitin inhibits polymerase II and III (27) . We conclude that the subcellular localization of MDDX28 depends directly or indirectly on active polymerase II transcription, because inhibition with the polymerase III-specific inhibitor, Tagetin (28), did not alter the localization significantly (Fig. 7B) . Treatment with the reversible transcription inhibitor DRB resulted in the disappearance of the nuclear signal from half of the cells after only 4 h. The signal was restored within 30 min after the removal of DRB even in the presence of 10 g/ml cycloheximide to inhibit de novo synthesis of proteins (Fig. 7C) . The same results were obtained when cycloheximide was added to the cell culture 1 h before the removal of DRB and kept on after the removal of DRB (data not shown). Thus the effect of transcription inhibition on MDDX28 localization was reversible.
Heterokaryon Assay-The distribution of the MDDX28-EGFP-N1 fusion protein was examined 1 h post-fusion of the COS-1 and NIH/3T3 cells. To distinguish the nuclei derived from mouse and monkey cells, the cells were counterstained with Hoechst 33258 after fixation (Fig. 6, B and C) . The fusion protein derived from the monkey cells was detected in the majority of the nuclei derived from the mouse cells, indicating that the protein had been exported from the nuclei or mitochondria of the monkey cells to the mouse nuclei. The fusion protein was also seen in essentially all the mitochondria of the heterokaryon cells (Fig. 6A) . When cells were treated with CCCP immediately after the fusion, the protein did not translocate to the mouse mitochondria, but the nuclear transport appeared to be normal (Fig. 6C) . DISCUSSION DNA replication, RNA transcription, and ribosome biogenesis are important mitochondrial processes. It has long been recognized that RNA helicase function must be a necessary component of these activities. We describe here a novel human RNA-dependent ATPase of the DEAD-box family, MDDX28, which to our knowledge is the first putative RNA helicase with mitochondrial localization to be described in mammals. The gene is located on the human chromosome 16q22.1 and is a typical housekeeping gene, being expressed in all tissues investigated. Correspondingly, its 5Ј end is covered by a CpG island (18) . The MDDX28 gene encodes a protein that displays ϳ30% similarity at the amino acid level with other putative RNA helicases over the best-conserved core region. It contains all the conserved DEAD-box helicase motifs.
The MDDX28 protein exhibits ATPase activity, which apparently depends on RNA, because RNase treatment of the RNAcontaining purified protein abolished this activity. We have, however, not been able to rescue the activity by adding back total RNA from COS-1 cells. This may suggest that MDDX28 needs a specific RNA target or an additional factor to interact with the RNA. Several other helicases (DbpA, Dbp5, and RhlB) have been suggested to need cofactors to be able to function as RNA helicases (reviewed in Ref. 29) . Further studies are needed to explore putative cofactors needed for MDDX28 function.
A common concept is that the highly conserved domains of the DEAD-box helicases contribute to their RNA helicase activity, whereas the N-and C-terminals of the proteins determine their functional specificity. MDDX28 has no significant homology with other hitherto described RNA helicases over its first 130 N-terminal amino acids, suggesting that MDDX28 has a novel function, although folding similarity with other helicases cannot be excluded. MDDX28 is not homologous to any of the four other mitochondrial RNA helicases described and does not show more similarity to these than to other RNA helicases.
The MDDX28 protein is localized both to the mitochondria and the nucleus, which is consistent with the putative MTS and the nuclear localization signal carried by the protein. A subfraction of the cells displayed the protein also in the nucleolus, raising the possibility that MDDX28 may have a function in relation to ribosomal RNA. We have found that the protein is very stable when COS-1 cells are treated with cycloheximide, making it possible to study the effect of inhibitors of transcription on the distribution of the protein. Unexpectedly, the RNA polymerase inhibitors, actinomycin D, DRB, and ␣-amanitin, caused the MDDX28-EGFP-N1 fusion protein to disappear from the nucleus of the majority of cells but remain in the mitochondria. The nuclear localization specifically depended on active RNA polymerase II transcription or products thereof and was not affected by inhibition of de novo protein synthesis. The effects of DRB on the subcellular localization of the fusion protein were shown to be reversible, as the protein returned to the nucleus when DRB was removed from the medium, in the presence of protein synthesis inhibitor. These results suggested that MDDX28 could shuttle to and from the nucleus, consistent with its putative nuclear import and export signals, and depending on ongoing RNA synthesis. Bearing in mind that MDDX28 can bind RNA, it is possible that the protein is involved in RNA processing or transport.
The shuttling ability of the fusion protein was studied further in a system independent of transcription inhibition using an interspecies heterokaryon assay. Untransfected NIH/3T3 mouse embryo cells were fused to MDDX28-EGFP-N1-transfected COS-1 cells derived from monkey kidney. A high concentration of cycloheximide was maintained throughout the experiment to prevent de novo synthesis of protein; therefore, all fusion protein present in the heterokaryons would have originated in the transfected COS-1 cells and have been present in its nucleus or mitochondria prior to the fusion. The heterokaryon assay clearly showed that the protein could shuttle to the mouse nucleus.
Unlike other shuttling proteins that mainly reside in the nucleus, the MDDX28 protein showed no detectable accumulation in the cytoplasm during the transcriptional inhibition. The protein was still found in the mitochondria of the transfected cells 24 h after the transcription inhibition. This suggested that either the protein was translocated from the nucleus to the cytoplasm where it was readily broken down and thus could not be observed or it was translocated from the nucleus to the mitochondria. It was therefore of interest to study the possibility for nucleo-mitochondrial transport further.
In the heterokaryon assay, the mitochondria of the heterokaryons, regardless of their origin, appeared to contain the fusion protein 1 h post cell fusion. However, when the cells were treated from the time of cell fusion with CCCP, which inhibits the import of the MDDX28-EGFP-N1 fusion protein to the mitochondria, the protein appeared to be transported normally to the nucleus of the mouse cells but did not translocate to the mitochondria. Excess protein did not appear to accumulate in the cytoplasm. This indicated that in the absence of CCCP, the fusion protein could be transported to the mitochondria derived from the mouse cells either from the nucleus or the mitochondria of the monkey cells.
To test whether the transport of MDDX28 could also occur in the opposite direction, from mitochondria to the nucleus, cells were treated with the reversible transcription inhibitor DRB. This caused the protein to be translocated from the nucleus. The protein reappeared very rapidly in the nucleus when DRB was removed and DRB-free medium was added. Because the experiment was performed in the presence of cycloheximide to inhibit new protein synthesis and the protein did not visibly accumulate in the cytoplasm upon transcription inhibition, the nuclear-localized protein could only have derived from protein that was pre-existing in the mitochondria. These results therefore suggest that the protein can also be transported from the mitochondria to the nucleus.
Several mitochondrial-matrix proteins have been found previously at unexpected locations in the cell (reviewed in Ref. 30) , suggesting the existence of a mechanism(s) for the export of proteins from the mitochondria. For nucleo-mitochondrial shuttling to be possible the protein must, however, retain its MTS after the mitochondrial import. Fractionation of cells and immunoblotting of the MDDX28 protein showed that the size of the protein in the nuclear and mitochondrial fractions was identical, indicating that the mitochondrial targeting signal peptide was not cleaved off when the protein located to the mitochondria.
In conclusion, we have cloned a novel human putative RNA helicase encoding a protein that is localized within mitochondria and nucleus. Our findings suggest that MDDX28 is transported between these two compartments, making it possible that MDDX28 is involved in communication between the mitochondria and nucleus. Molecular communication from the mitochondria to nucleus is a relatively uncharted phenomenon. Several pathways have been suggested but none have yet been discovered. MDDX28 might serve as a tool for studies of these processes.
